Mohammad-Reza Mahmoudian-Sani
Overview
Explore the profile of Mohammad-Reza Mahmoudian-Sani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahmoudian-Sani M, Fattahi N, Hashemzadeh Chaleshtori M, Asgharzade S
Exp Clin Transplant
. 2024 Mar;
22(2):148-155.
PMID: 38511985
Objectives: MicroRNAs play an important role in the development and function of neuron cells. Among these, the miRNA known as MIR96 is abundantly expressed in mammalian retina and significantly affects...
2.
Wojdasiewicz P, Turczyn P, Lach-Gruba A, Poniatowski L, Purrahman D, Mahmoudian-Sani M, et al.
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38396794
Rosavin, a phenylpropanoid in 's rhizome, and an adaptogen, is known for enhancing the body's response to environmental stress. It significantly affects cellular metabolism in health and many diseases, particularly...
3.
Poniatowski L, Woznica M, Wojdasiewicz P, Mela-Kalicka A, Romanowska-Prochnicka K, Purrahman D, et al.
Cells
. 2024 Jan;
13(2).
PMID: 38247816
Glioblastoma multiforme (GBM) represents the most common and aggressive malignant form of brain tumour in adults and is characterized by an extremely poor prognosis with dismal survival rates. Currently, expanding...
4.
Purrahman D, Shojaeian A, Poniatowski L, Piechowski-Jozwiak B, Mahmoudian-Sani M
Cell Mol Neurobiol
. 2023 Aug;
43(7):3435-3447.
PMID: 37561339
Stroke is a life-threatening medical condition and is a leading cause of disability. Cerebral ischemia is characterized by a distinct inflammatory response starting with the production of various cytokines and...
5.
Houshmandfar S, Khodadadi A, Mahmoudian-Sani M, Nashibi R, Rashno M
Immunobiology
. 2023 Jul;
228(5):152710.
PMID: 37478686
Background And Aim: The hyperactive nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a key factor for cytokine...
6.
Saeedi-Boroujeni A, Purrahman D, Shojaeian A, Poniatowski L, Rafiee F, Mahmoudian-Sani M
J Inflamm (Lond)
. 2023 Jan;
20(1):1.
PMID: 36658641
Immune dysregulation has been identified as a critical cause of the most common types of cardiovascular diseases (CVDs). Notably, the innate and adaptive immune responses under physiological conditions are typically...
7.
Yousefi H, Purrahman D, Jamshidi M, Lak E, Keikhaei B, Mahmoudian-Sani M
Clin Transl Oncol
. 2022 Jul;
24(11):2081-2089.
PMID: 35852681
T-cell acute lymphoblastic leukemia (T-ALL) is a malignancy caused by clonal proliferation of T-cell pre-cursors arising from the thymus. Although the optimized chemotherapy regimen could improve the outcome of such...
8.
Purrahman D, Yousefi Avarvand A, Paradowska-Gorycka A, Saki N, Karimpourian H, Jodat H, et al.
Future Oncol
. 2022 Jun;
18(22):2483-2494.
PMID: 35695559
Breast cancer is a common cancer in the female population. Despite remarkable progress in the treatment of this cancer, its exact etiology is still unknown. Since the first evidence of...
9.
Bahadoram M, Saeedi-Boroujeni A, Mahmoudian-Sani M, Hussaini H, Hassanzadeh S
Infez Med
. 2022 Mar;
30(1):41-50.
PMID: 35350251
Following the outbreak of the COVID-19 pandemic, millions of people around the world have been affected with SARS-CoV-2 infection. In addition to the typical symptoms, thrombotic events, lymphopenia, and thrombocytopenia...
10.
Saeedi-Boroujeni A, Nashibi R, Ghadiri A, Nakajima M, Salmanzadeh S, Mahmoudian-Sani M, et al.
Arch Med Res
. 2022 Mar;
53(4):368-377.
PMID: 35339280
Background: Tranilast is a potential NLRP3 inflammasome inhibitor that may relieve progressive inflammation due to COVID-19. Aim Of The Study: To evaluate the therapeutic effects of Tranilast in combination with...